Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 5 studies | 29% ± 9% | |
type II pneumocyte | 4 studies | 20% ± 3% | |
GABAergic neuron | 3 studies | 29% ± 9% | |
glutamatergic neuron | 3 studies | 44% ± 9% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 30% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 3581.98 | 89 / 89 | 99% | 33.69 | 890 / 901 |
prostate | 100% | 1515.24 | 244 / 245 | 98% | 21.04 | 493 / 502 |
stomach | 100% | 1543.58 | 358 / 359 | 98% | 24.61 | 280 / 286 |
intestine | 99% | 3567.03 | 959 / 966 | 97% | 29.40 | 513 / 527 |
brain | 100% | 2151.60 | 2634 / 2642 | 97% | 16.02 | 681 / 705 |
pancreas | 99% | 1414.02 | 325 / 328 | 97% | 14.84 | 172 / 178 |
thymus | 100% | 4174.17 | 653 / 653 | 92% | 42.89 | 557 / 605 |
lung | 99% | 2003.99 | 573 / 578 | 90% | 16.07 | 1044 / 1155 |
breast | 100% | 1669.05 | 459 / 459 | 89% | 15.58 | 990 / 1118 |
liver | 100% | 2012.50 | 226 / 226 | 83% | 13.75 | 337 / 406 |
bladder | 100% | 1268.90 | 21 / 21 | 82% | 14.98 | 414 / 504 |
adrenal gland | 100% | 2373.83 | 258 / 258 | 79% | 18.37 | 181 / 230 |
ovary | 93% | 739.68 | 168 / 180 | 80% | 11.18 | 342 / 430 |
skin | 100% | 2184.13 | 1803 / 1809 | 69% | 7.44 | 328 / 472 |
esophagus | 99% | 1161.60 | 1425 / 1445 | 69% | 10.24 | 127 / 183 |
uterus | 99% | 945.88 | 168 / 170 | 52% | 5.37 | 240 / 459 |
spleen | 100% | 1193.91 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.37 | 1 / 1 |
adipose | 100% | 1613.71 | 1203 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 1516.84 | 801 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1446.81 | 1330 / 1335 | 0% | 0 | 0 / 0 |
heart | 97% | 3658.96 | 836 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 66% | 8.04 | 53 / 80 |
peripheral blood | 47% | 313.63 | 433 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 28% | 1.91 | 8 / 29 |
tonsil | 0% | 0 | 0 / 0 | 24% | 1.59 | 11 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0005975 | Biological process | carbohydrate metabolic process |
GO_0002682 | Biological process | regulation of immune system process |
GO_0005615 | Cellular component | extracellular space |
GO_0005764 | Cellular component | lysosome |
GO_0070062 | Cellular component | extracellular exosome |
GO_0106330 | Molecular function | sialate 9-O-acetylesterase activity |
GO_0001681 | Molecular function | sialate O-acetylesterase activity |
GO_0106331 | Molecular function | sialate 4-O-acetylesterase activity |
Gene name | SIAE |
Protein name | Sialate O-acetylesterase (EC 3.1.1.53) (H-Lse) (Sialic acid-specific 9-O-acetylesterase) |
Synonyms | YSG2 |
Description | FUNCTION: Catalyzes the removal of O-acetyl ester groups from position 9 of the parent sialic acid, N-acetylneuraminic acid. |
Accessions | Q9HAT2 ENST00000545756.5 [Q9HAT2-2] ENST00000263593.8 [Q9HAT2-1] ENST00000618733.4 [Q9HAT2-2] |